Your doctor or pharmacist may already be aware of any possible drug interactions and may be monitoring you for them. Do not start, stop, or change the dosage of any medicine before checking with your doctor or pharmacist first.
Avoid taking MAO inhibitors (e.g., furazolidone, isocarboxazid, linezolid, moclobemide, phenelzine, procarbazine, rasagiline, selegiline, tranylcypromine) within 2 weeks before,...
Read moreDo you ever have one of those weeks when things go unaccountably right? I know what you’re thinking, but hear me out: I’m getting a... Read more »
In last week's Question of the Week, 18 of you shared your story of being misdiagnosed - often by a doctor who failed to listen or ask the... Read more »
This post is about taking a break in our routines. I’m here in LA, hanging out with a good friend. The last three or four weeks has been... Read more »
On Sunday, life dumped a very unpleasant surprise on me. Not unpleasant as in I will get over it unpleasant. No, this was the kind of... Read more »
Next week, October 4 - 10, is Mental Illness Awareness Week. In 1990, the United States Congress established the first week of October as... Read more »
Brand Name: Vyvanse Generic Name: lisdexamfetamine dimesylate Usage: Vyvanse has been approved by the Food and Drug Administration to treat... Read more »
Vyvanse is effective in treating adults with attention-deficit/hyperactivity disorder, according to new clinical trial results. In the study, 414... Read more »
According to the drug manufacturer Shire, the Food and Drug Administration has approved Vyvanse for the treatment of attention-deficit/hyperactivity... Read more »
Vyvanse, the daily medication to treat symptoms of attention-deficit/hyperactivity disorder, is now available in the United States. Vyvanse works... Read more »